OOS investigation SOP: GMP Compliance and Regulatory Expectations in US, UK and EU
OOS Investigation SOP: GMP Compliance and Regulatory Expectations in US, UK and EU OOS Investigation SOP: GMP Compliance and Regulatory Expectations in US, UK and EU Out of Specification (OOS) results pose significant challenges to pharmaceutical quality assurance processes. Ensuring compliance with regulatory expectations, particularly from entities such as the FDA, EMA, and MHRA, necessitates…
Read More “OOS investigation SOP: GMP Compliance and Regulatory Expectations in US, UK and EU” »